Angiogenesis inhibition augments the effect of imatinib in gastrointestinal stromal tumor

被引:3
|
作者
Cohen, Noah A. [1 ]
Zeng, Shan [1 ]
Kim, Teresa S. [1 ]
Cavnar, Michael J. [1 ]
Seifert, Adrian M. [1 ]
Sorenson, Eric C. [1 ]
Greer, Jonathan B. [1 ]
Crawley, Megan H. [1 ]
Green, Benjamin L. [1 ]
DeMatteo, Ronald P. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1016/j.jamcollsurg.2013.07.327
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:S140 / S140
页数:1
相关论文
共 50 条
  • [1] Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor
    Vitiello, Gerardo A.
    Medina, Benjamin D.
    Zeng, Shan
    Bowler, Timothy G.
    Zhang, Jennifer Q.
    Loo, Jennifer K.
    Param, Nesteene J.
    Liu, Mengyuan
    Moral, Alec J.
    Zhao, Julia N.
    Rossi, Ferdinand
    Antonescu, Cristina R.
    Balachandran, Vinod P.
    Cross, Justin R.
    DeMatteo, Ronald P.
    CLINICAL CANCER RESEARCH, 2018, 24 (04) : 972 - 984
  • [2] The inhibition of Endostar on the angiogenesis and growth of gastrointestinal stromal tumor xenograft
    Tian-bao Wang
    Xiu-qing Wei
    Wei-hao Lin
    Han-ping Shi
    Wen-guang Dong
    Clinical and Experimental Medicine, 2012, 12 : 89 - 95
  • [3] The inhibition of Endostar on the angiogenesis and growth of gastrointestinal stromal tumor xenograft
    Wang, Tian-bao
    Wei, Xiu-qing
    Lin, Wei-hao
    Shi, Han-ping
    Dong, Wen-guang
    CLINICAL AND EXPERIMENTAL MEDICINE, 2012, 12 (02) : 89 - 95
  • [4] Gastrointestinal stromal tumor (GIST) and imatinib
    Kubota T.
    International Journal of Clinical Oncology, 2006, 11 (3) : 184 - 189
  • [5] BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors
    Mu, Jianfeng
    Sun, Xuezeng
    Zhao, Zhipeng
    Sun, Hao
    Sun, Pengda
    CELL DEATH & DISEASE, 2021, 12 (11)
  • [6] BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors
    Jianfeng Mu
    Xuezeng Sun
    Zhipeng Zhao
    Hao Sun
    Pengda Sun
    Cell Death & Disease, 12
  • [7] Neoadjuvant imatinib for unresectable gastrointestinal stromal tumor
    Katz, D
    Segal, A
    Alberton, Y
    Jurim, O
    Reissman, P
    Catane, R
    Cherny, NI
    ANTI-CANCER DRUGS, 2004, 15 (06) : 599 - 602
  • [8] Imatinib mesylate for the treatment of gastrointestinal stromal tumor
    Cassier, Philippe A.
    Blay, Jean-Yves
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (05) : 623 - 634
  • [9] Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor
    Bauer, Sebastian
    Yu, Lynn K.
    Demetri, George D.
    Fletcher, Jonathan A.
    CANCER RESEARCH, 2006, 66 (18) : 9153 - 9161
  • [10] Prognostic significance of angiogenesis in gastrointestinal stromal tumor
    Imamura, Masakazu
    Yamamoto, Hidetaka
    Nakamura, Norimoto
    Oda, Yoshinao
    Yao, Takashi
    Kakeji, Yoshihiro
    Baba, Hideo
    Maehara, Yoshihiko
    Tsuneyoshi, Masazumi
    MODERN PATHOLOGY, 2007, 20 (05) : 529 - 537